Generare Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Employees
  • 36

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $23.1M

  • Investors
  • 11

Generare General Information

Description

Operator of a biotechnology company intended to discover novel drug leads of microbial origins. The company has developed a comprehensive map of the biosynthetic landscape and uses experimental data to predict which genes could yield valuable new molecules, enabling pharmaceutical companies and research institutions to access molecules that offer novel modes of action for drug development.

Contact Information

Website
www.generare.bio
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 4 Rue Maillard
  • 75011 Paris
  • France
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Life Sciences
Corporate Office
  • 4 Rue Maillard
  • 75011 Paris
  • France

Generare Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Generare Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Early Stage VC (Series A) 02-Apr-2026 $23.1M Completed Startup
3. Accelerator/Incubator 06-Nov-2025 Completed Startup
2. Seed Round 07-Oct-2024 $5.55M $5.55M Completed Startup
1. Accelerator/Incubator Completed Startup
To view Generare’s complete valuation and funding history, request access »

Generare Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Seed
Seed
To view Generare’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Generare Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a biotechnology company intended to discover novel drug leads of microbial origins. The company has develope
Drug Discovery
Paris, France
36 As of 2026

Paris, France
 

Paris, France
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Generare Competitors (2)

One of Generare’s 2 competitors is AQEMIA, a Venture Capital-Backed company based in Paris, France.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
AQEMIA Venture Capital-Backed Paris, France
WhiteLab Genomics Venture Capital-Backed Paris, France
You’re viewing 2 of 2 competitors. Get the full list »

Generare Patents

  • 1

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 1

    Pending

  • Expiring in next 12 mo

Generare Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025163168-A1 High-throughput methods for identifying and recovering gene clusters of interest Pending 31-Jan-2024

Generare Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Generare Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds
Daphni Venture Capital Minority
La French Tech Accelerator/Incubator
Alven Capital Partners Venture Capital Minority
Better Angle Venture Capital Minority
Galion.exe Venture Capital Minority
You’re viewing 5 of 11 investors. Get the full list »

Ready to get started?

Request a free trial

Generare FAQs

  • When was Generare founded?

    Generare was founded in 2022.

  • Where is Generare headquartered?

    Generare is headquartered in Paris, France.

  • What is the size of Generare?

    Generare has 36 total employees.

  • What industry is Generare in?

    Generare’s primary industry is Drug Discovery.

  • Is Generare a private or public company?

    Generare is a Private company.

  • What is Generare’s current revenue?

    The current revenue for Generare is .

  • How much funding has Generare raised over time?

    Generare has raised $28.7M.

  • Who are Generare’s investors?

    Daphni, La French Tech, Alven Capital Partners, Better Angle, and Galion.exe are 5 of 11 investors who have invested in Generare.

  • Who are Generare’s competitors?

    AQEMIA and WhiteLab Genomics are competitors of Generare.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process